Home Cart Sign in  
Chemical Structure| 1206163-45-2 Chemical Structure| 1206163-45-2

Structure of Solcitinib
CAS No.: 1206163-45-2

Chemical Structure| 1206163-45-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Solcitinib is a highly selective JAK1 inhibitor with IC50 value of 9.8 nM, with much less potency against JAK1 and JAK2 with IC50 values >100nM.

Synonyms: GLPG-0778; GSK-2586184; G154578

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Solcitinib

CAS No. :1206163-45-2
Formula : C22H23N5O2
M.W : 389.45
SMILES Code : O=C(C1CC1)NC2=NN3C(C4=CC=C(C(N5CC(C)(C)C5)=O)C=C4)=CC=CC3=N2
Synonyms :
GLPG-0778; GSK-2586184; G154578
MDL No. :MFCD26960569
InChI Key :MPYACSQFXVMWNO-UHFFFAOYSA-N
Pubchem ID :44603362

Safety of Solcitinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302
Precautionary Statements:P280-P305+P351+P338

Related Pathways of Solcitinib

epigenetics
RTK
JAK-STAT

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
MDSCs 10 µM 48 or 96 hours As a positive control, used to examine the proliferation, expansion, and differentiation of MDSCs into M-MDSCs PMC9467541
Porcine IgM+B cells 2 µM 24 hours Inhibited the phosphorylation of STAT1 and STAT3 proteins PMC7324671
CAMA1 1.0 µM 14 days JAK1 inhibitor Solcitinib had no impact on 3D spheroid growth compared to controls in all four cell lines, suggesting that regulation of p21 in FGFR1 amplified cells may occur through JAK2, but not JAK1. PMC10979625
MDA-MB-134 1.0 µM 14 days JAK1 inhibitor Solcitinib had no impact on 3D spheroid growth compared to controls in all four cell lines, suggesting that regulation of p21 in FGFR1 amplified cells may occur through JAK2, but not JAK1. PMC10979625
MCF7 1.0 µM 14 days JAK1 inhibitor Solcitinib had no impact on 3D spheroid growth compared to controls in all four cell lines, suggesting that regulation of p21 in FGFR1 amplified cells may occur through JAK2, but not JAK1. PMC10979625
T47D 1.0 µM 14 days JAK1 inhibitor Solcitinib had no impact on 3D spheroid growth compared to controls in all four cell lines, suggesting that regulation of p21 in FGFR1 amplified cells may occur through JAK2, but not JAK1. PMC10979625

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.57mL

0.51mL

0.26mL

12.84mL

2.57mL

1.28mL

25.68mL

5.14mL

2.57mL

References

 

Historical Records

Categories